title: [Efficacy of siRNA on feline leukemia virus replication in vitro].
abstract: Feline leukemia virus (FeLV) can lead to severe clinical signs in cats. Until now, there is no effective therapy for FeLV-infected cats. RNA interference-based antiviral therapy is a new concept. Specific small interfering RNA (siRNA) are designed complementary to the mRNA of a target region, and thus inhibit replication. Several studies have proven efficacy of siRNAs in inhibiting virus replication. The aim of this study was to evaluate the inhibitory potential of siRNAs against FeLV replication in vitro. siRNAs against the FeLV env gene and the host cell surface receptor (feTHTR1) which is used by FeLV-A for entry as well as siRNA that were not complementary to the FeLV or cat genome, were tested. Crandell feline kidney cells (CrFK cells) were transfected with FeLV-A/Glasgow-1. On day 13, infected cells were transfected with siRNAs. As control, cells were mock-transfected or treated with azidothymidine (AZT) (5 μg/ml). Culture supernatants were analyzed for FeLV RNA using quantitative real-time RT-PCR and for FeLV p27 by ELISA every 24 hours for five days. All siRNAs significantly reduced viral RNA and p27 production, starting after 48 hours. The fact that non-complementary siRNAs also inhibited virus replication may lead to the conclusion that unspecific mechanisms rather than specific binding lead to inhibition.
authors.forename: Melanie
authors.initials: M
authors.lastname: Lehmann
authors.forename: Karin
authors.initials: K
authors.lastname: Weber
authors.forename: Gisep
authors.initials: G
authors.lastname: Rauch
authors.forename: Regina
authors.initials: R
authors.lastname: Hofmann-Lehmann
authors.forename: Margaret J
authors.initials: MJ
authors.lastname: Hosie
authors.forename: Marina L
authors.initials: ML
authors.lastname: Meli
authors.forename: Katrin
authors.initials: K
authors.lastname: Hartmann
mesh_terms: D000818:Animals; D002415:Cats; D002460:Cell Line; D005256:Leukemia Virus, Feline / Q000235:genetics / Q000502:physiology*; D016582:Leukemia, Feline / Q000628:therapy / Q000821:virology; D034741:RNA, Small Interfering / Q000494:pharmacology*; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D014779:Virus Replication / Q000187:drug effects* / Q000235:genetics
chemical_list: D034741:RNA, Small Interfering; D012367:RNA, Viral